OrganoClick AB (ORGC) AI Stock Analysis

• Market Cap: kr186.42M
• Dividend Yield: N/A
• Average Volume (3M): 75.87K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.19
• Revenue Growth: -11.46%
• EPS Growth: -14.56%
• Country: SE
• Employees: 40
• Sector: Basic Materials
• Sector Strength: 72
• Industry: Chemicals - Specialty
• EPS (TTM): -0.04
• Shares Outstanding: 98,117,966
• 10 Day Avg. Volume: 115,621
• 30 Day Avg. Volume: 75,867
• PEG Ratio: 0.96
• Price to Book (P/B): 8.03
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -26.70
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: kr2.01
• Price Target Upside: 5.89% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 46 Neutral
• Price Target: kr2.00 ▲(5.26%Upside)

OrganoClick AB's overall stock score is primarily impacted by its weak financial performance, which poses significant risks to its financial health. The negative MACD and price below major moving averages indicate a bearish technical outlook. Additionally, the negative P/E ratio highlights valuation concerns, making the stock less attractive.

OrganoClick AB Business Overview & Revenue Model

Company Description

OrganoClick AB is a Swedish company specializing in the development and production of environmentally friendly chemical products and technologies. The company's core focus is on creating sustainable alternatives for traditional chemical solutions in sectors such as textiles, construction, and paper. OrganoClick's innovative technologies include biobased binders, water-repellent and flame-retardant coatings, and biodegradable polymers, all aiming to reduce environmental impact while maintaining high performance standards.

How the Company Makes Money

OrganoClick AB generates revenue through the sale of its proprietary environmentally friendly products and licensing of its technologies. The company's key revenue streams include the sale of biobased binders for nonwoven materials, water-repellent and flame-retardant treatments for textiles, and biodegradable binders for paper and packaging industries. Additionally, OrganoClick collaborates with various industry partners to integrate its sustainable solutions into their products, further expanding its market reach and revenue potential. Strategic partnerships and continuous innovation in green chemistry are significant factors contributing to the company's earnings growth.

OrganoClick AB Financial Statement Overview

Summary

OrganoClick AB faces significant financial challenges with declining revenue, persistent losses, and high leverage. Despite some improvements in EBITDA and operating cash flow, the overall financial position is weak, requiring strategic intervention.

Income Statement

OrganoClick AB has experienced fluctuating revenue with a decline in the latest year, leading to a negative revenue growth rate of -12.78%. Despite positive gross profit margins, the company is struggling with profitability, indicated by negative net profit and EBIT margins. The EBITDA margin has improved but remains low, reflecting ongoing operational challenges.

Balance Sheet

The balance sheet shows a concerning debt-to-equity ratio of 1.75, indicating high leverage, which poses a financial risk. The equity ratio of 22.82% is relatively low, suggesting limited asset-backed financing. Return on Equity remains negative due to ongoing net losses, highlighting the need for strategic improvement to enhance shareholder value.

Cash Flow

The cash flow statement reveals a negative free cash flow, with a free cash flow to net income ratio indicating insufficient cash generation to cover losses. Operating cash flow has improved but remains low in relation to net income. The company needs to focus on improving cash generation to support operations and reduce reliance on debt.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	124.45M	127.23M	145.87M	115.05M	110.06M	96.46M
Gross Profit	29.60M	31.84M	35.39M	12.94M	18.51M	20.20M
EBITDA	3.48M	5.71M	5.95M	-21.19M	-12.92M	-4.41M
Net Income	-19.37M	-17.97M	-15.77M	-41.62M	-31.03M	-19.52M
Balance Sheet
Total Assets	177.04M	126.98M	150.75M	162.86M	188.39M	152.80M
Cash, Cash Equivalents and Short-Term Investments	401.00K	538.00K	10.74M	15.20M	34.25M	32.03M
Total Debt	75.50M	50.56M	62.39M	60.68M	53.54M	43.36M
Total Liabilities	142.93M	89.15M	97.34M	95.30M	80.66M	69.86M
Stockholders Equity	25.78M	28.98M	44.58M	58.78M	100.33M	54.08M
Cash Flow
Free Cash Flow	-7.75M	-5.51M	-8.08M	-35.35M	-52.34M	-13.93M
Operating Cash Flow	3.52M	3.60M	533.00K	-21.22M	-37.69M	5.47M
Investing Cash Flow	-11.28M	-9.11M	-8.61M	-7.45M	-14.65M	-19.40M
Financing Cash Flow	-5.35M	-4.69M	3.60M	9.63M	54.56M	-15.19M

OrganoClick AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.90
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ORGC, the sentiment is Negative. The current price of 1.9 is below the 20-day moving average (MA) of 1.99, below the 50-day MA of 2.08, and below the 200-day MA of 2.51, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 41.30 is Neutral, neither overbought nor oversold. The STOCH value of 75.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:ORGC.

OrganoClick AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
POLYG	64 Neutral	€471.20M	28.16	-4.31%	2.17%	35.99%	95.51%
Sector *	58 Neutral	kr30.15B	-5.32	-5.02%	6.03%	6.97%	5.26%
NEXAM	57 Neutral	kr309.91M	―	-7.20%	―	-3.42%	-31.37%
SERT	47 Neutral	kr157.17M	―	-15.65%	―	-10.46%	-680.00%
ORGC	46 Neutral	kr186.42M	―	-55.62%	―	-11.46%	-14.56%